BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35869843)

  • 1. Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study.
    Malahe SRK; Hoek RAS; Dalm VASH; Broers AEC; den Hoed CM; Manintveld OC; Baan CC; van Deuzen CM; Papageorgiou G; Bax HI; Van Kampen JJ; Hellemons ME; Kho MML; de Vries RD; Molenkamp R; Reinders MEJ; Rijnders BJA
    Clin Infect Dis; 2023 Feb; 76(3):e172-e178. PubMed ID: 35869843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
    Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
    Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Selection of Sotrovimab Escape Variants in Severe Acute Respiratory Syndrome Coronavirus 2 Omicron-Infected Immunocompromised Patients.
    Gliga S; Lübke N; Killer A; Gruell H; Walker A; Dilthey AT; Thielen A; Lohr C; Flaßhove C; Krieg S; Pereira JV; Seraphin TP; Zaufel A; Däumer M; Orth HM; Feldt T; Bode JG; Klein F; Timm J; Luedde T; Jensen BO
    Clin Infect Dis; 2023 Feb; 76(3):408-415. PubMed ID: 36189631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-titer post-vaccine COVID-19 convalescent plasma for immunocompromised patients during the first omicron surge.
    Tayyar R; Wong LK; Dahlen A; Shu E; Pandey S; Liu AY
    Transpl Infect Dis; 2023 Apr; 25(2):e14055. PubMed ID: 36929619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of antiviral plus anti-spike monoclonal antibody combination therapy vs. monotherapy for high-risk immunocompromised patients with mild-to-moderate SARS-CoV2 infection during the Omicron era: A prospective cohort study.
    Calderón-Parra J; Gutiérrez-Villanueva A; Ronda-Roca G; Jimenez MLM; de la Torre H; Ródenas-Baquero M; Paniura-Pinedo M; Lozano-Llano C; Pintos-Pascual I; Fernández-Cruz A; Ramos-Martínez A; Muñez-Rubio E
    Int J Antimicrob Agents; 2024 Mar; 63(3):107095. PubMed ID: 38244814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Vaccination and Early Monoclonal Antibody Therapy on Coronavirus Disease 2019 Outcomes in Organ Transplant Recipients During the Omicron Wave.
    Solera JT; Árbol BG; Alshahrani A; Bahinskaya I; Marks N; Humar A; Kumar D
    Clin Infect Dis; 2022 Dec; 75(12):2193-2200. PubMed ID: 35445690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Infection With the Omicron SARS-CoV-2 Variant in a Cohort of Kidney and Kidney Pancreas Transplant Recipients: Clinical Features, Risk Factors, and Outcomes.
    Wong G; Rowlandson M; Sabanayagam D; Ginn AN; Kable K; Sciberras F; Au E; Draper J; Arnott A; Sintchenko V; Dwyer DE; Chen SCA; Kok J
    Transplantation; 2022 Sep; 106(9):1860-1866. PubMed ID: 35675438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of lung transplant recipients infected with SARS-CoV-2/Omicron/B.1.1.529: a Nationwide German study.
    Kneidinger N; Hecker M; Bessa V; Hettich I; Wald A; Wege S; Nolde AB; Oldigs M; Syunyaeva Z; Wilkens H; Gottlieb J
    Infection; 2023 Jun; 51(3):749-757. PubMed ID: 36083405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of COVID-19 among Hospitalized Patients: Omicron Remains a Severe Threat for Immunocompromised Hosts.
    Nevejan L; Ombelet S; Laenen L; Keyaerts E; Demuyser T; Seyler L; Soetens O; Van Nedervelde E; Naesens R; Geysels D; Verstrepen W; Cattoir L; Martens S; Michel C; Mathieu E; Reynders M; Evenepoel A; Hellemans J; Vanhee M; Magerman K; Maes J; Matheeussen V; Boogaerts H; Lagrou K; Cuypers L; André E
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sotrovimab Resistance and Viral Persistence After Treatment of Immunocompromised Patients Infected With the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant.
    Huygens S; Oude Munnink B; Gharbharan A; Koopmans M; Rijnders B
    Clin Infect Dis; 2023 Feb; 76(3):e507-e509. PubMed ID: 35867699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sotrovimab in Hospitalized Patients with SARS-CoV-2 Omicron Variant Infection: a Propensity Score-Matched Retrospective Cohort Study.
    Woo MS; Brehm TT; Fischer M; Heyer A; Wichmann D; Jordan S; Nörz D; Lütgehetmann M; Addo MM; Lohse AW; Schmiedel S; Kluge S; Schulze Zur Wiesch J
    Microbiol Spectr; 2023 Feb; 11(1):e0410322. PubMed ID: 36475890
    [No Abstract]   [Full Text] [Related]  

  • 12. [Analysis of clinical characteristics of 362 vaccinated or unvaccinated patients infected by novel coronavirus Omicron variant].
    Feng Q; Wang Z; Yu H; Shi L; Xu L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 May; 34(5):459-464. PubMed ID: 35728844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the Omicron variant truly less virulent in solid organ transplant recipients?
    Anjan S; Khatri A; Viotti JB; Cheung T; Garcia LAC; Simkins J; Loebe M; Phancao A; O'Brien CB; Sinha N; Ciancio G; Vianna RM; Andrews D; Abbo LM; Guerra G; Natori Y
    Transpl Infect Dis; 2022 Dec; 24(6):e13923. PubMed ID: 35915957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal Antibody Therapy in Kidney Transplant Recipients With Delta and Omicron Variants of SARS-CoV-2: A Single-Center Case Series.
    Fernandes G; Devresse A; Scohy A; De Greef J; Yombi JC; Belkhir L; Darius T; Mourad M; Buemi A; Kabamba B; Goffin E; Kanaan N
    Kidney Med; 2022 Jun; 4(6):100470. PubMed ID: 35493029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.
    Vinh DC; Gouin JP; Cruz-Santiago D; Canac-Marquis M; Bernier S; Bobeuf F; Sengupta A; Brassard JP; Guerra A; Dziarmaga R; Perez A; Sun Y; Li Y; Roussel L; Langelier MJ; Ke D; Arnold C; Whelan M; Pelchat M; Langlois MA; Zhang X; Mazer BD;
    Lancet Healthy Longev; 2022 Mar; 3(3):e166-e175. PubMed ID: 35224524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and outcomes of allogeneic hematopoietic stem cell transplantation recipients with coronavirus disease 2019 caused by the Omicron variant: a prospective, observational cohort study.
    Fan S; Mo X; Zhang X; Xu L; Wang Y; Yan C; Chen H; Zhang Y; Cheng Y; Sun Y; Chen Y; Chen Y; Han W; Wang J; Wang F; Xu Z; Huang X
    Ann Hematol; 2024 Apr; 103(4):1333-1344. PubMed ID: 38381172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
    Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
    PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving impact of the COVID-19 pandemic on lung transplant recipients: A single-center experience.
    Sindu D; Razia D; Bay C; Padiyar J; Grief K; Buddhdev B; Arjuna A; Abdelrazek H; Mohamed H; McAnally K; Omar A; Walia R; Schaheen L; Tokman S
    J Heart Lung Transplant; 2024 Mar; 43(3):442-452. PubMed ID: 37852512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination.
    Dapporto F; Marchi S; Leonardi M; Piu P; Lovreglio P; Decaro N; Buonvino N; Stufano A; Lorusso E; Bombardieri E; Ruello A; Viviani S; Molesti E; Trombetta CM; Manenti A; Montomoli E
    J Immunol Res; 2022; 2022():4813199. PubMed ID: 36093434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.